A Simple Validated Scale to Measure Urgency

Journal of Urology

Volumn 179, Issue 3, 2008, Pages 1000-1005

  Al Buheissi, Salah ^a   Khasriya, Rajvinder ^a   Maraj, Barry H ^a   Malone Lee, James ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

bladder; overactive; questionnaires; urge; urinary bladder; urinary incontinence; validation studies publication type

Indexed keywords

IMIPRAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; SOLIFENACIN; TOLTERODINE;

ADD ON THERAPY; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTRUCT VALIDITY; CONTROLLED DRUG RELEASE; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DRUG EFFICACY; EXPERIMENT; FEMALE; HUMAN; HUMAN CELL; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MONITORING; MONOTHERAPY; OVERACTIVE BLADDER; PRESCRIPTION; PRIORITY JOURNAL; RATING SCALE; RECORDING; STATISTICAL SIGNIFICANCE; SYMPTOM; TEST RETEST RELIABILITY; TREATMENT RESPONSE; URINARY URGENCY; URINE INCONTINENCE; VALIDATION STUDY;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; URINARY BLADDER, OVERACTIVE; URINATION DISORDERS;

EID: 39149119949     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.10.075     Document Type: Article

References (19)

1. Milsom I., Abrams P., Cardozo L., Roberts R.G., Thuroff J., and Wein A.J. How widespread are the symptoms of an overactive bladder and how are they managed?. A population-based prevalence study. BJU Int 87 (2001) 760
2. Stewart W.F., VanRooyen J.B., Cundiff G.W., Abrams P., Herzog A.R., Corey R., et al. Prevalence and burden of overactive bladder in the United States. World J Urol 20 (2003) 327
3. Chapple C.R., Artibani W., Cardozo L.D., Castro-Diaz D., Craggs M., Haab F., et al. The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects. BJU Int 95 (2005) 335
4. Rudy D., Cline K., Harris R., Goldberg K., and Dmochowski R. Multicenter phase III trial studying trospium chloride in patients with overactive bladder. Urology 67 (2006) 275
5. Nitti V.W., Dmochowski R., Appell R.A., Wang J.T., Bavendam T., and Guan Z. Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia. BJU Int 97 (2006) 1262
6. Cardozo L., Lisec M., Millard R., van Vierssen T.O., Kuzmin I., Drogendijk T.E., et al. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 172 (2004) 1919
7. Chapple C.R., Martinez-Garcia R., Selvaggi L., Toozs-Hobson P., Warnack W., Drogendijk T., et al. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 48 (2005) 464
8. Hay-Smith J., Herbison P., Ellis G., and Morris A. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev (2005) CD005429.
9. Martin J.L., Williams K.S., Abrams K.R., Turner D.A., Sutton A.J., Chapple C., et al. Systematic review and evaluation of methods of assessing urinary incontinence. Health Technol Assess 10 (2006) 1
10. Rabin J.M., McNett J., and Badlani G.H. A computerized voiding diary. J Reprod Med 41 (1996) 801
11. Rabin J.M., McNett J., and Badlani G.H. "Compu-Void II": the computerized voiding diary. J Med Syst 20 (1996) 19
12. Cardozo L., and Dixon A. Increased warning time with darifenacin: a new concept in the management of urinary urgency. J Urol 173 (2005) 1214
13. Bland J.M., and Altman D.G. Cronbach's alpha. BMJ 314 (1997) 572
14. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307
15. Deyo R.A., Diehr P., and Patrick D.L. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 12 (1991) 142S
16. Ghei M., and Malone-Lee J. Using the circumstances of symptom experience to assess the severity of urgency in the overactive bladder. J Urol 174 (2005) 972
17. Ghei M., Miller R., and Malone-Lee J. Case series data to encourage randomized trials of bladder retraining compared to antimuscarinic agents. J Urol 175 (2006) 1411
18. Benson K., and Hartz A.J. A comparison of observational studies and randomized, controlled trials. N Engl J Med 342 (2000) 1878
19. Fader M., Glickman S., Haggar V., Barton R., Brooks R., and Malone-Lee J. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial. J Urol 177 (2007) 208